论文部分内容阅读
再生障碍性贫血是一种严重危害人类健康的血液病,主要的治疗方法有骨髓移植、免疫抑制疗法,以及中医药等。近年来随着循证医学兴起,人们对再障认识的更加深入,再障的定义、分型以及治疗路径等都发生了一些新的变化,如何利用这些新进展加快再障中医规范化诊治,如何对起病缓急不同、轻重程度各异的再障患者选择恰当的中西医治疗方案,常常是中医界面临的困惑之一。目前我国尚无治疗再障的规范诊治指南,结合再障诊疗的新进展和近期的中医文献探讨再障的中西医结合规范化诊疗的思路和方法。
Aplastic anemia is a serious blood disease that endangers human health. The main treatments include bone marrow transplantation, immunosuppressive therapy, and traditional Chinese medicine. In recent years, with the rise of EBM, some new changes have taken place in people’s understanding of RP, such as the definition, classification and treatment path of RP, and how to make use of these new advances to speed up the standardization of TCM for aplastic anemia It is often one of the puzzles confronting the Chinese medicine community to choose appropriate Chinese and Western medicine treatment programs for patients with aplastic anemia who have different onset and different severity of severity. At present, there is no standard treatment guidelines for treatment of aplastic anemia in our country, combined with the new progress of the diagnosis and treatment of aplastic anemia and recent TCM literature to explore the ideas and methods of standardized diagnosis and treatment of the combination of TCM and Western medicine.